Unichem Laboratories Limited (UNICHEMLAB.NS)
INR 675.95
(0.13%)
INR 675.95
(0.13%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 31.69 Billion INR | -0.74% |
| 2022 | 31.93 Billion INR | -3.79% |
| 2021 | 33.18 Billion INR | 6.18% |
| 2020 | 31.25 Billion INR | -0.6% |
| 2019 | 31.44 Billion INR | -0.15% |
| 2018 | 31.49 Billion INR | -1.23% |
| 2017 | 31.88 Billion INR | 109.01% |
| 2016 | 15.25 Billion INR | 18.8% |
| 2015 | 12.84 Billion INR | 9.89% |
| 2014 | 11.68 Billion INR | 2.1% |
| 2013 | 11.44 Billion INR | 6.73% |
| 2012 | 10.72 Billion INR | 8.71% |
| 2011 | 9.86 Billion INR | 11.94% |
| 2010 | 8.81 Billion INR | 10.07% |
| 2009 | 8 Billion INR | 13.92% |
| 2008 | 7.02 Billion INR | 16.57% |
| 2007 | 6.02 Billion INR | 1.34% |
| 2006 | 5.94 Billion INR | 16.83% |
| 2005 | 5.09 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 31.69 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 31.69 Billion INR | -0.74% |
| 2023 Q2 | 30.69 Billion INR | 0.0% |
| 2022 Q4 | 31.93 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 31.63 Billion INR | 0.0% |
| 2022 FY | 31.93 Billion INR | -3.79% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 31.36 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 33.18 Billion INR | 0.0% |
| 2021 FY | 33.18 Billion INR | 6.18% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 31.25 Billion INR | -0.6% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 31.19 Billion INR | 0.0% |
| 2020 Q4 | 31.25 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 31.44 Billion INR | -0.15% |
| 2019 Q4 | 31.44 Billion INR | 0.0% |
| 2019 Q2 | 30.85 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 FY | 31.49 Billion INR | -1.23% |
| 2018 Q4 | 31.49 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q3 | 42.83 Billion INR | 0.0% |
| 2017 FY | 31.88 Billion INR | 109.01% |
| 2017 Q4 | 31.88 Billion INR | -25.55% |
| 2016 FY | 15.25 Billion INR | 18.8% |
| 2016 Q4 | 15.25 Billion INR | 0.0% |
| 2015 FY | 12.84 Billion INR | 9.89% |
| 2014 FY | 11.68 Billion INR | 2.1% |
| 2013 FY | 11.44 Billion INR | 6.73% |
| 2012 FY | 10.72 Billion INR | 8.71% |
| 2011 FY | 9.86 Billion INR | 11.94% |
| 2010 FY | 8.81 Billion INR | 10.07% |
| 2009 FY | 8 Billion INR | 13.92% |
| 2008 FY | 7.02 Billion INR | 16.57% |
| 2007 FY | 6.02 Billion INR | 1.34% |
| 2006 FY | 5.94 Billion INR | 16.83% |
| 2005 FY | 5.09 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -939.156% |
| Aarti Drugs Limited | 24.32 Billion INR | -30.299% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | -22.743% |
| Ajanta Pharma Limited | 46.38 Billion INR | 31.671% |
| Alembic Limited | 23.28 Billion INR | -36.095% |
| Alkem Laboratories Limited | 155.74 Billion INR | 79.651% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 50.829% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -193.995% |
| Bal Pharma Limited | 3.2 Billion INR | -889.218% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -6631.441% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -161.095% |
| Brooks Laboratories Limited | 904.45 Million INR | -3404.152% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -2046.066% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | -17.497% |
| Divi's Laboratories Limited | 154.7 Billion INR | 79.513% |
| Eris Lifesciences Limited | 70.48 Billion INR | 55.037% |
| Granules India Limited | 55.2 Billion INR | 42.595% |
| Ind-Swift Limited | 6.54 Billion INR | -384.26% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -1360.002% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 20.65% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 72.556% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -1220.221% |
| Medicamen Biotech Limited | 2.94 Billion INR | -976.096% |
| Medico Remedies Limited | 961.95 Million INR | -3194.697% |
| Wockhardt Limited | 76.49 Billion INR | 58.565% |
| Orchid Pharma Limited | 15.53 Billion INR | -103.964% |
| RPG Life Sciences Limited | 5.12 Billion INR | -517.962% |
| Shilpa Medicare Limited | 30.93 Billion INR | -2.462% |
| Sigachi Industries Limited | 6.94 Billion INR | -356.575% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | -35.061% |
| Vaishali Pharma Limited | 799.55 Million INR | -3863.875% |
| Wanbury Limited | 3.43 Billion INR | -822.681% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 89.176% |
| FDC Limited | 24.68 Billion INR | -28.413% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -763.886% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -314.224% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 91.821% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | -11.189% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -172.022% |
| Laurus Labs Limited | 83.87 Billion INR | 62.211% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -850.544% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -44.649% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -3019.092% |
| Hester Biosciences Limited | 6.62 Billion INR | -378.502% |
| Ipca Laboratories Limited | 111.01 Billion INR | 71.451% |
| Venus Remedies Limited | 6.26 Billion INR | -405.615% |
| ZIM Laboratories Limited | 4.46 Billion INR | -609.308% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 92.968% |
| Morepen Laboratories Limited | 12.93 Billion INR | -145.077% |
| Neuland Laboratories Limited | 18.32 Billion INR | -72.946% |
| Sequent Scientific Limited | 15.4 Billion INR | -105.75% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -40.604% |
| Valiant Laboratories Limited | 3.42 Billion INR | -824.85% |
| Windlas Biotech Limited | 6.26 Billion INR | -406.118% |
| Hikal Limited | 24.87 Billion INR | -27.429% |
| Innova Captab Limited | 13.2 Billion INR | -139.942% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -298.981% |
| Themis Medicare Limited | 5.66 Billion INR | -459.543% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -41.211% |
| Mankind Pharma Limited | 119.63 Billion INR | 73.508% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 77.927% |
| Sakar Healthcare Limited | 3.88 Billion INR | -715.456% |
| Albert David Limited | 4.97 Billion INR | -536.425% |
| Lupin Limited | 239.97 Billion INR | 86.793% |
| Gufic Biosciences Limited | 10.92 Billion INR | -190.089% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 96.292% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | -352.576% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -683.204% |
| Piramal Enterprises Limited | 826.05 Billion INR | 96.163% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 78.957% |
| NATCO Pharma Limited | 69.06 Billion INR | 54.109% |
| Suven Life Sciences Limited | 2.84 Billion INR | -1012.43% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -1678.785% |
| Strides Pharma Science Limited | 58.39 Billion INR | 45.728% |
| Indoco Remedies Limited | 21.44 Billion INR | -47.774% |
| Alpa Laboratories Limited | 1.82 Billion INR | -1635.47% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -2000.73% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -515.359% |